Navigation Links
Alere's Dr. Ron Loeppke to Speak on 'Health and Productivity as a Business Strategy' at First Annual IBI/NBCH Health and Productivity Forum
Date:2/11/2009

-- Loeppke to discuss recent findings showing that health-related productivity costs are significantly higher than medical and pharmacy costs

-- Presentation includes real-world insights into how employers can use research findings to develop integrated health and productivity enhancements

-- Conditions such as depression, obesity, arthritis and musculoskeletal disorders are significant cost drivers for nation's employers

LOS ANGELES, Feb. 11 /PRNewswire/ -- Ron Loeppke, M.D., M.P.H., EVP of Health and Productivity Strategy for Alere (www.alere.com), will speak on the topic of "Health and Productivity as a Business Strategy" at The Integrated Benefits Institute (IBI) and The National Business Coalition on Health (NBCH) , First Annual IBI/NBCH Health and Productivity Forum. The IBI/NBCH Conference takes place February 9-11, 2009 at the Hyatt Regency Century Plaza in Los Angeles. Dr. Loeppke will speak Wednesday, Feb. 11 at the 10:10 a.m. General Session. Alere, a member of the Inverness Medical Innovations family of companies, is recognized as one of the nation's leading providers of comprehensive health management services.

"U.S. employers today are significantly underestimating the overall costs associated with poor employee health, while also failing to fully assess the diseases and health conditions that drive these costs," said Dr. Loeppke. "We want to help employers understand that one of the best ways to lower costs is to provide programs that encourage health and wellness."

With more than 20 years of clinical and physician executive experience, Loeppke is well-qualified to speak on the topic. Dr. Loeppke is Board-Certified in Preventive Medicine and Fellowship-trained in Occupational Medicine. He is a Fellow of the American College of Occupational and Environmental Medicine (ACOEM - www.acoem.org.) and the American College of Preventive Medicine (ACPM) and currently serves on the Board of Directors for ACOEM as well as the Board of Directors of Integrated Benefits Institute (IBI).

The presentation will include new "real-world" insights and applications for employers, based on published data from a multi-employer research study conducted by Dr. Loeppke and others. It shows the total costs of poor health and helps to highlight the link between employee health and productivity.

Dr. Pamela Hymel, Corporate Medical Director of Cisco Systems, one of the employers that participated in the research, will share a case study of how Cisco used this and other related data to shape its benefits strategies. She will also give highlights of the innovative integrated health and productivity enhancement initiatives Cisco uses, as well as its new state-of-the-art worksite medical facility, the Cisco LifeConnections Health Center (http://www.ciscolifeconnections.com).

In addition, David Sensibaugh, Director of Integrated Health for Eastman Chemical Company, will also share his company's integrated health strategy and how they used the information from this study.

One of the most significant study findings is that health-related productivity costs are between two and four times higher than medical and pharmacy costs. Researchers note that health conditions with the highest absenteeism/presenteeism costs are often overlooked because they do not generate the highest medical costs, yet they drive total health-related costs. When full costs were measured - rather than medical costs alone - it was found that health conditions such as depression, obesity, arthritis, back/neck musculoskeletal problems and anxiety disorders took on new significance in driving total health-related costs for employers.

The results suggest that when healthcare costs are either viewed in a silo or without the broader context of "full cost", the cost impact of a given condition may be seriously underestimated. Accounting for absenteeism and presenteeism in addition to medical and pharmacy costs present a more accurate picture of the full costs that companies bear because of poor employee health.

The first phase of the research study was completed in 2007. Findings from the second phase are expected to be released this spring. The study gathered data from 10 employers and 50,000 employee respondents and analyzed more than 1 million medical and pharmacy claims.

About Alere

Alere(www.alere.com) is a member of the Inverness Medical Innovations (www.invernessmedical.com) family of companies and represents the union of Alere Medical, Paradigm Health and Matria Healthcare. Alere, a Latin verb, meaning "to care for" or "to support", offers the most patient-centered health management services available from a single provider in the industry. Alere services provide health interventions that are designed for the entire lifespan from pre-cradle (high risk pregnancy and NICU management) to end-of-life care (complex care) as well as the continuum of health from wellness (health and productivity programs) to prevention for those at risk for illnesses.


'/>"/>
SOURCE Alere
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. U.S. Preventive Medicine Appoints Ron Loeppke, M.D. as Co-Chairman of Its National Advisory Board
2. New Poll Shows Public Distrusts Flawed Healthcare Approach Favored by Governor and Speaker in AB 8
3. Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference
4. General Colin Powell Speaks Out for Prostate Cancer Prevention
5. Billians HealthDATA GM Speaking on Dreamforce 07 Panel
6. 2007 Speakers Golf Tournament Sets 5-Year Fundraising Record
7. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
8. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
9. Los Angeles Jewish Home Support Group Continues High-Profile Speaker Program With Noted Legal Scholar and Expert Laurie L. Levenson
10. Women for Women International Congolese Country Director, Christine Karumba, Speaks Out About the Rape Epidemic in the Democratic Republic of the Congo.
11. Autism Speaks Applauds Supreme Court Decision Upholding Families Right to Challenge IEPs Without First Trying Out School District Proposed Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... ... wellness products to enhance people’s everyday lives, recently attended the January ECRM Trade ... , ATP Science is known for its large range of supplements that keep ...
(Date:1/20/2017)... ... ... Michael and Betsy Brauser celebrated 5 years of Betsy’s participation in a ... has been life-saving as she has been on the trial for more than six ... ovarian cancer in 2009. She underwent standard chemotherapy but a year later went to ...
(Date:1/20/2017)... ... 20, 2017 , ... Vitamin Well has launched two new ... have been produced in collaboration with Zlatan Ibrahimovic and have been developed to ... a successful launch in Sweden last year, the next generation sports drinks VW+001 ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “The Angel”: ... the Lord has set out for each of his children. “The Angel” is the ... School of Music in New York City, and impassioned writer. , When asked of ...
(Date:1/20/2017)... ... ... fine examination of how God handles sin, including how to let go of lingering guilt ... over ten long years has been waiting to release this powerful insight about forgiveness that ... serving the Lord for over twenty years, and he has been preaching and teaching the ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... -- James Gilbart , ... 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ...      ... in a supplement to European Oncology & Haematology ... by James Gilbart and Axel ...
(Date:1/19/2017)... , Jan. 19, 2017   Science Exchange , ... to announce that the first five replication studies ... have been published in eLife today. Despite intense ... the first practical evaluation of reproducibility rates that ... studies. Unlike other assessments of reproducibility, the results ...
Breaking Medicine Technology: